Boston Biomedica Wins $700K SBIR Grant to Commercialize PCT Technology | GenomeWeb

NEW YORK, March 14 - Boston Biomedica on Thursday said it has been awarded a $701,000 Phase II Small Business Innovation Research grant to help develop and commercialize its Pressure Cycling Technology.

The technology is used to "release DNA, RNA, and proteins from cells and tissues, with particular emphasis on hard-to-lyse biomaterials," Boston Biomedica said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.